Randomized phase 3 study of lenalidomide versus chlorambucil as first-line therapy for older patients with chronic lymphocytic leukemia (the ORIGIN trial)

被引:22
作者
Chanan-Khan, A. [1 ]
Egyed, M. [2 ]
Robak, T. [3 ]
Martinelli de Oliveira, F. A. [4 ]
Echeveste, M. A. [5 ]
Dolan, S. [6 ]
Desjardins, P. [7 ]
Blonski, J. Z. [3 ]
Mei, J. [8 ]
Golany, N. [8 ]
Zhang, J. [8 ]
Gribben, J. G. [9 ]
机构
[1] Mayo Clin, Div Hematol & Oncol, Jacksonville, FL 32224 USA
[2] Kaposi Mor Oktato Korhaz, Dept Internal Med, Kaposvar, Hungary
[3] Med Univ Lodz, Dept Hematol, Lodz, Poland
[4] Hosp Erasto Gaertner, Dept Oncol, Curitiba, Parana, Brazil
[5] Hosp Univ Donostia, Hematol Serv, San Sebastian, Spain
[6] St Johns Hosp, Div Hematol, St John, NB, Canada
[7] Hosp Charles LeMoyne, Dept Hematol, Greenfield Pk, PQ, Canada
[8] Celgene Corp, Summit, NJ USA
[9] Barts Canc Inst, Ctr Haemato Oncol, London, England
关键词
D O I
10.1038/leu.2017.47
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1240 / 1243
页数:5
相关论文
共 7 条
[1]   Lenalidomide as initial therapy of elderly patients with chronic lymphocytic leukemia [J].
Badoux, Xavier C. ;
Keating, Michael J. ;
Wen, Sijin ;
Lee, Bang-Ning ;
Sivina, Mariela ;
Reuben, James ;
Wierda, William G. ;
O'Brien, Susan M. ;
Faderl, Stefan ;
Kornblau, Steven M. ;
Burger, Jan A. ;
Ferrajoli, Alessandra .
BLOOD, 2011, 118 (13) :3489-3498
[2]   Assessment of fludarabine plus cyclophosphamide for patients with chronic lymphocytic leukaemia (the LRF CLL4 Trial): a randomised controlled trial [J].
Catovsky, D. ;
Richards, S. ;
Matutes, E. ;
Oscier, D. ;
Dyer, M. J. S. ;
FBezares, R. ;
Pettitt, A. R. ;
Hamblin, T. ;
Milligan, D. W. ;
Child, J. A. ;
Hamilton, M. S. ;
Dearden, C. E. ;
Smith, A. G. ;
Bosanquet, A. G. ;
Davis, Z. ;
Brito-Babapulle, V. ;
Else, M. ;
Wade, R. ;
Hillmen, P. .
LANCET, 2007, 370 (9583) :230-239
[3]   Clinical efficacy of lenalidomide in patients with relapsed or refractory chronic lymphocytic leukemia: Results of a phase II study [J].
Chanan-Khan, Asher ;
Miller, Kena C. ;
Musial, Laurie ;
Lawrence, David ;
Padmanabhan, Swaminathan ;
Takeshita, Kenichi ;
Porter, Carl W. ;
Goodrich, David W. ;
Bernstein, Zale P. ;
Wallace, Paul ;
Spaner, David ;
Mohr, Alice ;
Byrne, Catriona ;
Hernandez-Ilizaliturri, Francisco ;
Chrystal, Cynthia ;
Starostik, Petr ;
Czuczman, Myron S. .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (34) :5343-5349
[4]   Single-Agent Lenalidomide in the Treatment of Previously Untreated Chronic Lymphocytic Leukemia [J].
Chen, Christine I. ;
Bergsagel, P. Leif ;
Paul, Harminder ;
Xu, Wei ;
Lau, Anthea ;
Dave, Nimisha ;
Kukreti, Vishal ;
Wei, Ellen ;
Leung-Hagesteijn, Chungyee ;
Li, Zhi Hua ;
Brandwein, Joseph ;
Pantoja, Mariela ;
Johnston, James ;
Gibson, Spencer ;
Hernandez, Tiffany ;
Spaner, David ;
Trudel, Suzanne .
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (09) :1175-1181
[5]   First-line therapy with fludarabine compared with chlorambucil does not result in a major benefit for elderly patients with advanced chronic lymphocytic leukemia [J].
Eichhorst, Barbara F. ;
Busch, Raymonde ;
Stilgenbauer, Stephan ;
Stauch, Martina ;
Bergmann, Manuela A. ;
Ritgen, Matthias ;
Kranzhoefer, Nicole ;
Rohrberg, Robert ;
Soeling, Ulrike ;
Burkhard, Oswald ;
Westermann, Anne ;
Goede, Valentin ;
Schweighofer, Carmen D. ;
Fischer, Kirsten ;
Fink, Anna-Maria ;
Wendtner, Clemens M. ;
Brittinger, Guenter ;
Doehner, Hartmut ;
Emmerich, Bertold ;
Hallek, Michael .
BLOOD, 2009, 114 (16) :3382-3391
[6]   Lenalidomide induces complete and partial remissions in patients with relapsed and refractory chronic lymphocytic leukemia [J].
Ferrajoli, Alessandra ;
Lee, Bang-Ning ;
Schlette, Ellen J. ;
O'Brien, Susan M. ;
Gao, Hui ;
Wen, Sijin ;
Wierda, William G. ;
Estrov, Zeev ;
Faderl, Stefan ;
Cohen, Evan N. ;
Li, Changping ;
Reuben, James M. ;
Keating, Michael J. .
BLOOD, 2008, 111 (11) :5291-5297
[7]   Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia. [J].
Rai, KR ;
Peterson, BL ;
Appelbaum, FR ;
Kolitz, J ;
Elias, L ;
Shepherd, L ;
Hines, J ;
Threatte, GA ;
Larson, RA ;
Cheson, BD ;
Schiffer, CA .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (24) :1750-1757